MPS PHARMA & MEDICAL, INC. – Trademark Portfolio

Entity Type: 03

MPS PHARMA & MEDICAL, INC. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 5 filings in this category. The portfolio also extends into Class 20 (Furniture) across 2 Nice Classification classes. Currently, 1 trademark is registered and 3 are pending. Notable registered marks include OPTIDROPPER. The owner is based in BREA, CA.

465 N. BERRY STREET

BREA, CA 92821

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MPS PHARMA & MEDICAL, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (5 filings)

Surgical, medical, dental and veterinary apparatus and instruments

20
Furniture (2 filings)

Furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker

Frequently Asked Questions

How many trademarks does MPS PHARMA & MEDICAL, INC. have?

MPS PHARMA & MEDICAL, INC. has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 pending, 3 abandoned.

What trademark classes does MPS PHARMA & MEDICAL, INC. file in?

MPS PHARMA & MEDICAL, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 20 (Furniture). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are MPS PHARMA & MEDICAL, INC.'s most well-known trademarks?

MPS PHARMA & MEDICAL, INC.'s registered trademark portfolio includes well-known marks such as OPTIDROPPER. These are among 1 currently registered trademark in the portfolio.

What is MPS PHARMA & MEDICAL, INC.'s trademark registration success rate?

MPS PHARMA & MEDICAL, INC. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 3 applications are pending review.